PACB Stock Analysis: Buy, Sell, or Hold?
PACB - Pacific Biosciences of California, Inc.
$2.54
0.03 (1.20%)
▲
5d:
+56.79%
30d:
+92.42%
90d:
+53.01%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When PACB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PACB is 35.1% above its trading range ($1.88). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PACB is 35.1% above its trading range ($1.88). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: PACB is currently trading at $2.54, which is considered extended relative to its 30-day fair value range of $1.18 to $1.88.
Technical Outlook: Technically, PACB is in a uptrend. Immediate support is located at $1.34, while resistance sits at $2.65.
Market Sentiment: PACB scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $2.16. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PACB is in a uptrend. Immediate support is located at $1.34, while resistance sits at $2.65.
Market Sentiment: PACB scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $2.16. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.18 -
$1.88
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
5.3%
Protect Your Profits
PACB is technically overbought (RSI 86). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+35.1% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 15.1% above Wall St target ($2.16)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.18 -
$1.88
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.34
Resistance Level
$2.65
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.32
Wall Street Target
$2.16
(-15.1%)
Revenue Growth (YoY)
-1.9%
Profit Margin
-82.5%
Share & Embed Analysis
Last updated: October 03, 2026 11:36 AM ET
Data refreshes hourly during market hours. Next update: 12:36 PM
Data refreshes hourly during market hours. Next update: 12:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PACB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 38 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$83 | 60 BUY |
Advanced PACB Option Strategies
Professional options setups generated by AI based on today's PACB price and gamma walls.
